Saval is an experienced health economist and behavioural economist, recognised for his expertise in decision-analytic modelling, behavioural change, behavioural economics, and multicriteria decision analysis applied to health. With a diverse background that includes working in academia, research, and consulting environments in Australia, Malaysia, Nepal, and the UK, Saval has gained extensive international experience and collaborated with experts from various countries. He holds a PhD in Pharmacoepidemiology and Pharmacoeconomics from the University of Queensland in Australia.

As the Senior Research Associate in Health Economics at HEC, he brings a wealth of experience and a strategic approach to projects of diverse nature. His exceptional analytical skills and meticulous attention to detail make him an invaluable asset for conducting robust cost-effectiveness analyses, health technology assessments, pricing and reimbursement strategies, and multicriteria decision analyses. Saval’s international experience and extensive publications in renowned journals highlight his outstanding contributions to the field of health economics and behavioural science. With his innovative and evidence-based approach, Saval is frequently sought-after by pharmaceutical companies, government agencies, and non-governmental organisations for projects aimed at improving health outcomes, optimising resource allocation, and informing policy decisions. His professionalism and unwavering dedication to excellence make him a trusted expert in the field, delivering exceptional results for clients seeking cutting-edge solutions to complex healthcare challenges.